The main objective of PANCAID is to provide a minimally invasive blood test using a comprehensive panel of liquid biopsy diagnostics (LBx) for early detection of pancreatic cancer and the malignant conversion of premalignant to invasive lesions.
To achieve this key aim, PANCAID will address the following specific objectives in the respective work packages.